Long and Short QT Syndrome: Deletion/Duplication Panel
Condition Description
Long QT syndrome (LQTS) is characterized by a QT interval that is
prolonged on the surface electrocardiogram and a predisposition to early
after depolarizations and torsades de pointes. LQTS can present
clinically with palpitations, presyncope, syncope, or sudden cardiac
death.
Short QT syndrome (SQTS) is characterized by an abnormally short QT interval and susceptibility to both ventricular tachyarrhythmias and atrial fibrillation.
References:
Short QT syndrome (SQTS) is characterized by an abnormally short QT interval and susceptibility to both ventricular tachyarrhythmias and atrial fibrillation.
References:
- Dolmatova et al. (2013). Curr Cardiol Rep, 15:389.
- OMIM
Genes (12)
Your search may have returned a result for a gene alias. Click here for a full list of genes and their aliases.
Indications
This test is indicated for:
- Confirmation of a clinical diagnosis of Long QT syndrome (LQTS) and Short QT syndrome (SQTS).
- Carrier testing in adults with a family history of Long QT syndrome (LQTS) and Short QT syndrome (SQTS).
Methodology
Deletion/Duplication Analysis: DNA isolated from peripheral blood is hybridized to a CGH array to
detect deletions and duplications. The targeted CGH array has
overlapping probes which cover the entire genomic region.
Please note that a "backbone" of probes across the entire genome are included on the array for analytical and quality control purposes. Rarely, off-target copy number variants causative of disease may be identified that may or may not be related to the patient's phenotype. Only known pathogenic off-target copy number variants will be reported. Off-target copy number variants of unknown clinical significance will not be reported.
Please note that a "backbone" of probes across the entire genome are included on the array for analytical and quality control purposes. Rarely, off-target copy number variants causative of disease may be identified that may or may not be related to the patient's phenotype. Only known pathogenic off-target copy number variants will be reported. Off-target copy number variants of unknown clinical significance will not be reported.
Detection
Deletion/Duplication Analysis: Detection is limited to duplications and deletions. The CGH array will
not detect point or intronic mutations. Results of molecular analysis
must be interpreted in the context of the patient's clinical and/or
biochemical phenotype.
Specimen Requirements
When sample fails to meet the acceptable criteria, please call 470.378.2200 and ask to speak with a laboratory genetic counselor (eglgc@egl-eurofins.com).
Submit only 1 of the following specimen types
Type: Whole Blood
Specimen Requirements:
In EDTA (purple top) tube:Infants (<2 years): 2-3 ml
Children (>2 years): 3-5 ml
Older Children & Adults: 5-10 ml
Specimen Collection and Shipping: Ship sample at room temperature with overnight delivery.
Type: Isolated DNA
Specimen Requirements:
In microtainer: 10 ugIsolation using the QiagenTM Puregene kit for DNA extraction is recommended.
Specimen Collection and Shipping: Refrigerate until time of shipment. Ship sample within 5 days of collection at room temperature with overnight delivery.
Related Tests
- Comprehensive Cardiovascular: Sequencing Panel
- Comprehensive Cardiovascular: Deletion/Duplication Panel
- Long and Short QT Syndrome: Sequencing Panel